Distribution of pfmdr1 polymorphisms in Plasmodium falciparum isolated from Southern Thailand

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Mungthin, Mathirut ^a   Intanakom, Somchai ^b   Suwandittakul, Nantana ^a   Suida, Preeyaporn ^b   Amsakul, Sakultip ^b   Sitthichot, Naruemon ^a   Thammapalo, Suwich ^b   Leelayoova, Saovanee ^a  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE; MEFLOQUINE; QUININE;

ALLELE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTINUOUS CULTURE; CONTROLLED STUDY; GENE DOSAGE; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GIEMSA STAIN; HUMAN; IC 50; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALARIA; MALAYSIA; NONHUMAN; PARASITE CULTIVATION; PARASITE ISOLATION; PFCRT GENE; PFMDR1 GENE; PHENOTYPE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION SYSTEM; PROTOZOAL GENETICS; REAL TIME POLYMERASE CHAIN REACTION; THAILAND;

ANTIMALARIALS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; THAILAND;

EID: 84899129486     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-117     Document Type: Article

References (43)

1. WHO, Global Report on Antimalarial Drug Efficacy and Drug Resistance 2000-2010 Geneva: World Health Organization 2010
2. WHO, Guidelines for the Treatment of Malaria Geneva: World Health Organization 2006
3. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
4. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
5. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naudé B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
6. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Cooper RA, Ferdig MT, Su XZ, Ursos LM, Mu J, Nomura T, Fujioka H, Fidock DA, Roepe PD, Wellems TE, Mol Pharmacol 2002 61 35 42 10.1124/mol.61.1.35 11752204
7. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF, Nature 1990 345 255 258 10.1038/345255a0 2185424
8. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF, Nature 2000 403 906 909 10.1038/35002615 10706290
9. Highl-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D, J Infect Dis 2001 183 1535 1538 10.1086/320195 11319692
10. Role of Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes on in vitro chloroquine resistance in isolates of Plasmodium falciparum from Thailand. Setthaudom C, Tan-ariya P, Sitthichot N, Khositnithikul R, Suwandittakul N, Leelayoova S, Mungthin M, Am J Trop Med Hyg 2011 85 606 611 10.4269/ajtmh.2011.11-0108 21976558
11. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Wilson CM, Volkman SK, Thaithong S, Martin RK, Kyle DJ, Milhous WK, Wirth DF, Mol Biochem Parasitol 1993 57 151 160 10.1016/0166-6851(93)90252-S 8426608
12. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Cowman AF, Galatis D, Thompson JK, Proc Natl Acad Sci U S A 1994 91 1143 1147 10.1073/pnas.91.3.1143 8302844
13. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, Kawamoto F, Miller RS, Meshnick SR, Antimicrob Agent Chemother 2003 47 2418 2423 10.1128/AAC.47.8.2418-2423.2003
14. Pfmdr1 genotyping and in vivo mefloquine resistance on the Thai-Myanmar border. Nelson AL, Purfield A, McDaniel P, Uthaimongkol N, Buathong N, Sriwichai S, Miller RS, Wongsrichanalai C, Meshnick SR, Am J Trop Med Hyg 2005 72 586 592 15891133
15. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Duraisingh MT, Cowman AF, Acta Trop 2005 94 181 190 10.1016/j.actatropica.2005. 04.008 15876420
16. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC, Mol Biochem Parasitol 2000 108 12 23
17. Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum. Poyomtip T, Suwandittakul N, Sitthichot N, Khositnithikul R, Tan-ariya P, Mungthin M, Malar J 2012 11 7 10.1186/1475-2875-11-7 22221394
18. Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum. Mungthin M, Khositnithikul R, Sitthichot N, Suwandittakul N, Wattanaveeradej V, Ward SA, Na-Bangchang K, Am J Trop Med Hyg 2010 83 1005 1009 10.4269/ajtmh.2010.10-0339 21036827
19. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, Mol Biochem Parasitol 1993 58 283 292 10.1016/0166-6851(93)90050-8 8479452
20. Human malaria parasites in continuous culture. Trager W, Jensen JB, Science 1976 193 673 675 10.1126/science.781840 781840
21. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Desjardins RE, Canfield J, Haynes D, Chulay JD, Antimicrob Agents Chemother 1979 16 710 718 10.1128/AAC.16.6.710 394674
22. Plasmodium falciparum: a simple polymerase chain reaction method for differentiating strains. Wooden J, Gould EE, Paull AT, Sibley CH, Exp Parasitol 1992 75 207 212 10.1016/0014-4894(92)90180-I 1516668
23. A molecular marker for chloroquine-resistant falciparum malaria. Djimdé A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourté Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152
24. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Duraisingh MT, Roper C, Walliker D, Warhurst DC, Mol Microbiol 2000 36 955 961 10.1046/j.1365-2958.2000.01914.x 10844681
25. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742
26. Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates. Bickii J, Basco LK, Ringwald P, J Clin Microbiol 1998 36 243 247 9431956
27. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. Basco LK, Le Bras J, Ann Trop Med Parasitol 1994 88 137 144 8067809
28. Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal. Hatin I, Trape JF, Legros F, Bauchet J, Le Bras J, Bull World Health Org 1992 70 363 367 1638665
29. The patterns of mutation and amplification of Plasmodium falciparum pfcrt and pfmdr1 genes in Thailand during the year 1988 to 2003. Mungthin M, Suwandittakul N, Chaijaroenkul W, Rungsrihirunrat K, Harnyuttanakorn P, Seugorn A, Na Bangchang K, Parasitol Res 2010 107 539 545 10.1007/s00436-010-1887-x 20449753
30. Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184 F mutation in Cambodia. Vinayak S, Alam MT, Sem R, Shah NK, Susanti AI, Lim P, Muth S, Maguire JD, Rogers WO, Fandeur T, Barnwell JW, Escalante AA, Wongsrichanalai C, Ariey F, Meshnick SR, Udhayakumar V, J Infect Dis 2010 201 1551 1560 10.1086/651949 20367478
31. Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border. Phompradit P, Wisedpanichkij R, Muhamad P, Chaijaroenkul W, Na-Bangchang K, Acta Trop 2011 120 130 135 10.1016/j.actatropica.2011.07.003 21777558
32. Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand. Rojanawatsirivej C, Vijaykadga S, Amklad I, Wilairatna P, Looareesuwan S, Southeast Asian J Trop Med Public Health 2003 34 536 541 15115123
33. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A, Wongsrichanalai C, Trop Med Int Health 2006 11 211 219 10.1111/j.1365-3156.2005.01557.x 16451346
34. WHO, Malaria in the Greater Mekong Subregion: Regional and Country Profiles Geneva: World Health Organization 2010
35. Genetic diversity and population structure of Plasmodium falciparum in Thailand, a low transmission country. Pumpaibool T, Arnathau C, Durand P, Kanchanakhan N, Siripoon N, Suegorn A, Sitthi-Amorn C, Renaud F, Harnyuttanakorn P, Malar J 2009 8 155 10.1186/1475-2875-8-155 19602241
36. The detection of pfcrt and pfmdr1 point mutations as molecular markers of chloroquine drug resistance, Pahang, Malaysia. Atroosh WM, Al-Mekhlafi HM, Mahdy MA, Surin J, Malar J 2012 11 251 10.1186/1475-2875-11-251 22853645
37. Association between chloroquine resistance phenotypes and point mutations in pfcrt and pfmdr1 in Plasmodium falciparum isolates from Thailand. Rungsihirunrat K, Chaijareonkul W, Seugorn A, Na-Bangchang K, Thaithong S, Acta Trop 2009 109 37 40 10.1016/j.actatropica.2008.09.011 18950599
38. Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar. Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Tichit M, Jahevitra M, Rabearimanana S, Raherinjafy R, Mercereau-Puijalon O, Durand R, Ménard D, PLoS One 2010 5 13281 10.1371/journal.pone.0013281 20967251
39. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimdé AA, Kouriba B, Taylor TE, Plowe CV, J Infect Dis 2003 187 1870 1875 10.1086/375419 12792863
40. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76 T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Wang X, Mu J, Li G, Chen P, Guo X, Fu L, Chen L, Su X, Wellems TE, Am J Trop Med Hyg 2005 72 410 414 15827277
41. Pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Hayward R, Saliba KJ, Kirk K, Mol Microbiol 2005 55 1285 1295 10.1111/j.1365-2958.2004.04470.x 15686571
42. Fitness consequences of Plasmodium falciparum pfmdr1 polymorphisms inferred from ex vivo culture of Ugandan parasites. Ochong E, Tumwebaze PK, Byaruhanga O, Greenhouse B, Rosenthal PJ, Antimicrob Agents Chemother 2013 [Epub ahead of print]
43. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum. Osman ME, Mockenhaupt FP, Bienzle U, Elbashir MI, Giha HA, Infect Genet Evol 2007 7 52 59 10.1016/j.meegid.2006.03.008 16690361